Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre (Other)
Overall Status
Completed
CT.gov ID
NCT01077102
Collaborator
(none)
24
1
2
23
1

Study Details

Study Description

Brief Summary

The main purpose of this project is to establish the additional value of eccentric versus concentric exercise to optimize muscle function in patients with severe COPD. With this pilot project the investigators expect that an eccentric endurance training protocol adapted to severe COPD patients will lead to gains in muscle strength, the primary outcome, and cellular adaptation (muscle morphology and oxidative capacity, mitochondrial respiratory capacity) when compared to a concentric training approach.

This information will be essential if the investigators want to design and power a randomized clinical trial that will allow assessing effectiveness of this novel rehabilitation approach.

Condition or Disease Intervention/Treatment Phase
  • Other: Eccentric exercise training
N/A

Detailed Description

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness that is both preventable and treatable. Dyspnea is the most important symptom that COPD patients experience and this can have a major impact on their daily live. While COPD is characterized by a spectrum of disease severity, most patients experience poor exercise intolerance attributable to ventilatory limitation as well as peripheral muscle fatigue, ultimately leading to severe disability.

Endurance exercise is an important component of pulmonary rehabilitation and is aimed at preventing this decline in functional capacity. The effects of pulmonary rehabilitation are largely attributable to the exercise training component involving concentric muscle contractions, traditionally trough dynamic, large muscle exercise on a cycle ergometer or treadmill. However, many patients are unable to partake and benefit from such rehabilitation because of locomotor muscle weakness and severe ventilatory limitation that prevent them from exercising at intensities sufficient to provoke improvements in cardioventilatory and skeletal muscle function. Eccentric exercise is known for its unique physiologically fundamental characteristics: the lower metabolic demand for a same power output and greater muscle gains compared to the concentric exercise. For this reason, eccentric endurance training has been proposed as a novel adjunctive rehabilitative countermeasure for certain chronic diseases (such as coronary disease and COPD) and can play an important role for patients with advanced disease.

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Eccentric Training as Novel Rehabilitation for COPD
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Dec 1, 2012
Actual Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Eccentric exercise training

Other: Eccentric exercise training
The eccentric exercise training will be performed using a specially built cycle ergo meter where the pedals are driven in backward direction by an electric motor, which has to overcome the adjustable resistance of the electromagnetic brake. During eccentric cycle ergometry patients have to resist the turning pedals.

Active Comparator: Concentric exercise training

Other: Eccentric exercise training
The eccentric exercise training will be performed using a specially built cycle ergo meter where the pedals are driven in backward direction by an electric motor, which has to overcome the adjustable resistance of the electromagnetic brake. During eccentric cycle ergometry patients have to resist the turning pedals.

Outcome Measures

Primary Outcome Measures

  1. Muscle strength [At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program]

    This outcome will be measured using an isokinetic dynamometer

Secondary Outcome Measures

  1. Muscle cellular adaptation [At baseline and at the end of the training program]

    Muscle biopsy will include evaluation of cross-sectional area, fiber type, mitochondrial oxidative capacity, mitochondrial respiratory capacity, respiratory oxygen species and expression of genes involved in muscle atrophy and hypertrophy (Atrogin-1, MurF1, FoxO, MyoD, Myostatin)

  2. Exercise capacity (maximal and submaximal) [At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program]

  3. Physical Activity [At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program]

    Physical activity levels will be measured by an accelerometer and by the CHAMPS questionnaire.

  4. Health-related quality of life (HRQL) [At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program]

    The HRQL will be measured by the Chronic Respiratory Questionnaire

  5. Muscle pain and creatine kinase(CK)levels [Muslce pain will be assessed in the beginning and in the end of each session and CK levels at baseline, after the fisrt week of training, midway through and the after the last week of training]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 80 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • male patients with severe COPD (FEV1/FVC < 0.70 and FEV1 ≤ 50% predicted of normal)

  • Patients aged 40 to 80 years old in whom exercise is not contraindicated

  • Current and ex-smokers

  • Patients who do not require oxygen therapy

Exclusion Criteria:
  • Patients presenting neurological or orthopedic problems, morbid obesity, acute medical condition or recent exacerbations (in the last four weeks)

  • Patients with recent or current participation in a rehabilitation program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Montreal Chest Institute Montreal Quebec Canada H2X 2P4

Sponsors and Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

Investigators

  • Principal Investigator: Jean Bourbeau, M.D, M.Sc., McGill University Health Centre/Research Institute of the McGill University Health Centre
  • Principal Investigator: Tanja Taivassalo, Ph.D., McGill University Health Centre/Research Institute of the McGill University Health Centre
  • Principal Investigator: Helene Perrault, Ph.D., McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jean Bourbeau, Jean Bourbeau, McGill University Health Centre/Research Institute of the McGill University Health Centre
ClinicalTrials.gov Identifier:
NCT01077102
Other Study ID Numbers:
  • MUHC Pilot Project 2007
First Posted:
Feb 26, 2010
Last Update Posted:
Aug 24, 2018
Last Verified:
Aug 1, 2018
Keywords provided by Jean Bourbeau, Jean Bourbeau, McGill University Health Centre/Research Institute of the McGill University Health Centre
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2018